z-logo
open-access-imgOpen Access
Can TROP2 be used as a prognostic marker in endometrioid endometrial carcinoma?
Author(s) -
Serkan Çelik,
Özgür Çelik
Publication year - 2020
Publication title -
indian journal of pathology and microbiology/indian journal of pathology and microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 31
eISSN - 0974-5130
pISSN - 0377-4929
DOI - 10.4103/ijpm.ijpm_783_19
Subject(s) - medicine , carcinoma , hysterectomy , exact test , malignancy , oncology , stage (stratigraphy) , clear cell carcinoma , pathology , biology , paleontology
Endometrioid-type endometrial carcinoma is the most common malignancy of the female genital tract in developed countries. The prognosis greatly depends on the grade and stage of the disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here